REFERENCES
- Devonec M, Ogden C, Perrin P, Carter S. Clinical response to transurethral microwave thermotherapy is thermal dose dependent. Eur Urol 1996; 23: 267–74.
- Ogden CW, Reddy P, Johnson H, Ramsay JVV, Carter SStC. Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet 1993; 341: 14–7.
- de Wildt MJAM, Hubregtse M, Ogden C, et al. A 12 month study of the placebo effect in transurethral microwave thermotherapy. Br J Urol 1996; 77: 221–7.
- de la Rosette BMCH, de Wildt MJAM, Alvizatos G, Froeling FMJA, Debruyne FMJ. Transurethral micro-wave thermotherapy (TUMT) in benign prostatic hyperplasia: placebo versus TUMT. Urology 1994; 44: 58–63.
- de la Rosette BMCH, d'Ancona FCH, Debruyne FMJ. Current status of thermotherapy of the prostate. J Urol 1997; 157: 430–8.
- de Wildt MJAM, d'Ancona FCH, Hubregtse M, Carter SStC, Debruyne FMJ, de la Rosette BMCH. Three-year followup of patients treated with lower energy micro-wave thermotherapy. J Urol 1996; 156: 1959–63.
- Homma Y, Aso Y. Transurethral microwave thermo-therapy for benign prostatic hyperplasia. J Endourol 1993; 3: 261–5.
- Blute M, Hanson K, Lynch J, et al. United States Pro statron TUMT Study-4 year followup and quality of life. J Urol 1996; 155\(Part 2): 403A.
- Glass JM, Bdesha AS, Witherow RO. Microwave thermotherapy: a long-term follow-up of 67 patients from a single center. Br J Urol 1998; 81: 377–82.
- Keijzers GB, Fransisca EA, d'Ancona FC, Kiemeney LA, Debruyne FM, de la Rosette JJ. Long-term results of lower energy transurethral microwave thermotherapy. J Urol 1998; 159: 1966–72.
- Dmhlin L, Frugard J, Farstad M. Serum concentrations of prostate-specific antigen after diagnostic procedures and transurethral microwave thermotherapy of benign prostatic hyperplasia. Scand J Clin Lab Invest 1996; 56: 269–73.
- Dmhlin L, Frugard J. Transurethral microwave thermo-therapy for management of benign prostatic hyperplasia: one-year results with the PRIMUS U ± R device. Scand J Urol Nephrol 1997; 31: 57–61.
- Dmhlin L, Frugard J. Three-year follow-up after transurethral microwave thermotherapy (TUMT) for management of benign prostatic hyperplasia using the PRIMUS U ± R device. Scand J Urol Nephrol 1999; 33: 217–21.
- Siegel S Nonparametric statistics for the behavioral sciences. Tokyo: McGraw-Hill Kogakusha; 1956.
- Noruis MJ SPSS® for Windows. Base system user's guide, release 6.1. Chicago, IL: PSS; 1994.
- Roos N, Wennberg JE, Malenka DJ, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989; 230: 1120–4.
- Emberton M, Neal DE, Black N, et al. The effect of prostatectomy on symptom severity and quality of life. Br J Urol 1996; 77: 233–47.
- Lepor H. Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Urology 1995; 45: 406–15.
- McConell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 1998; 338: 557–63.
- Lepor H, Williford WO, Barry MJ, et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N Engl J Med 1996; 335: 533–9.
- Perachino M, Bozzo W, Puppo P. Vitali A, Ardoino S, Ferro MA. Does transurethral thermotherapy induce a long-term alpha blockade? Eur Urol 1993; 23: 299–301.
- de la Rosette BMCH, Tubaro A, 116fner K, Carter S. Transurethral microwave thermotherapy: past, present and future. World J Urol 1994; 12: 352–6.
- Bolmsjö M, Wagrell L, Bailin A, Eliasson T, Erlandsson B-E, Mattiasson A. The heat is on—but how? A comparison of TUMT devices. Br J Urol 1996; 78: 564–72.
- Larson TR, Blute ML, Tri JL, Whitlock SV. Contrasting heating patterns and efficiency of the Prostatron and Targis microwave antennae for thermal treatment of benign prostatic hyperplasia. Urology 1998; 51: 908–15.
- Wagrell L, Schelin S, Bolmsjö M, Brudin L. Intra-pro static temperature monitoring during transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia. J Urol 1998; 159: 1583–7.